Federal grants to Bedrock Therapeutics, Inc.
Bedrock Therapeutics, Inc. in Raleigh, North Carolina received $3.1 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Vision Research, with $2.6 million. In fiscal 2025 it was awarded $1.4 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.1 million
- Awards7
- Awarded in FY 2025$1.4 million
- Largest award$1.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $500,073 |
| FY 2022 | 1 | $261,080 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $975,387 |
| FY 2025 | 4 | $1.4 million |
Programs that fund Bedrock Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Vision Research | 4 | $2.6 million |
| Allergy and Infectious Diseases Research | 1 | $304,501 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $261,080 |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $1 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $3.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Prevention of corneal transplant rejection using AAV-BDRK-401 therapy - project description corneal blindness is one of the leading causes of vision loss worldwide, with 10 million individuals having bilateral corneal blindness globally. Allogeneic corneal transplantation (CT) to treat genetic and a | Vision Research | August 30, 2024 | $1.8 million |
| Immunosuppressive gene therapy for ocular graft vs host disease - abstract bedrock therapeutics, inc., is developing a method of controlling the immunologic response to allogenic hematopoietic stem cell transplants (HSCT) with the aim of preventing ocular manifestations of graft vs host disease (ogv | Vision Research | August 19, 2021 | $328,150 |
| Vector mediated anti-vascular and anti-inflammatory therapy for amd - abstract bedrock therapeutics, inc., is developing a method of controlling the inflammatory, vascular, and immunologic response in neovascular age-related macular degeneration (NAMD). Namd is the leading cause of blindness in peop | Vision Research | July 21, 2025 | $310,952 |
| Intramuscular administration of aav vectors encoding soluble PD-L1 for rheumatoid arthritis treatment - rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects the joints. Current therapies aim to reduce synovial inflammation and pain, and prevent joint destruction by t | Allergy and Infectious Diseases Research | September 19, 2025 | $304,501 |
| Rational design of aav vectors with human hepatocyte tropism and neutralizing antibody evasion - adeno-associated virus (AAV) vectors have been successfully applied in clinical trials in patients with diverse disorders. Two aav based gene therapy drugs have been recently approved by the fda. Luxturn | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 29, 2022 | $261,080 |
| Prevention of corneal transplant rejection using aav-hla-g combination therapy | Vision Research | February 26, 2021 | $171,923 |
| Intramuscular administration of aav vectors encoding soluble PD-L1 for rheumatoid arthritis treatment - rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects the joints. Current therapies aim to reduce synovial inflammation and pain, and prevent joint destruction by t | Arthritis, Musculoskeletal and Skin Diseases Research | September 19, 2025 | $1 |
Questions people ask
How much federal grant money does Bedrock Therapeutics, Inc. get?
$3.1 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Bedrock Therapeutics, Inc. the most?
The Department of Health and Human Services, with $3.1 million in 7 awards.
What is Bedrock Therapeutics, Inc.'s largest federal grant?
$1.8 million under Vision Research, with its first action in the period on August 30, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Bedrock Therapeutics, Inc.?
Its largest are Vision Research, Allergy and Infectious Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Raleigh
- North Carolina Department of Health & Human Services
- North Carolina Department of Public Instruction
- Transportation North Carolina Department
- North Carolina Department of Public Safety
- North Carolina Department of Environmental Quality
- North Carolina Department of Public Instruction
- Department of Commerce North Carolina
- Department of Information Technology
Largest federal grant recipients in North Carolina · Federal grants in North Carolina